Contrast-enhanced ultrasound: A filter role in AJCC stage I/II melanoma patients

Oncology

Volumn 79, Issue 5-6, 2011, Pages 370-375

  De Giorgi, Vincenzo ^a   Gori, Alessia ^a   Grazzini, Marta ^a   Rossari, Susanna ^a   Marino, Gaetano ^a   D'Elia, Giovanni ^b   Crocetti, Emanuele ^c   Roselli, Giuliana ^b   Innocenti, Paolo ^b   Dini, Mario ^a   Lotti, Torello ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b AOUC   (Italy)

^c ISPO   (Italy)

Author keywords

Contrast enhanced ultrasound; Lymphoscintigraphy; Sentinel lymph node, biopsy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CONTRAST ENHANCED ULTRASOUND; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MALE; MELANOMA; PREDICTIVE VALUE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; ULTRASOUND;

ADULT; AGED; AGED, 80 AND OVER; CONTRAST MEDIA; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; SENTINEL LYMPH NODE BIOPSY;

EID: 79952827921     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000323494     Document Type: Article

References (29)

1. Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG, Fleming ID, Gershenwald JE, Houghton A Jr, Kirkwood JM, Mc- Masters KM, Mihm MF, Morton DL, Reintgen DS, Ross MI, Sober A, Thompson JA, Thompson JF: Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001; 19: 3635-3648. (Pubitemid 32786276)
2. Tsao H, Atkins MB, Sober AJ: Management of cutaneous melanoma. N Engl J Med 2004; 351: 998-1012.
3. Paek SC, Sober AJ, Tsao H, Mihm MC Jr, Johnson TM: Cutaneous melanoma; in Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ (eds): Fiztpatrick's Dermatology in General Medicine. New York, Mc Graw-Hill, 2008; 124: 1149-1151.
4. Balch CM, Gershenwald JE, Soong S, Thompson JF, Atkins MB, Byrd DR, Buzaid AC, Cochran AJ, Coit DG, Ding S, Eggermont AM, Flaherty KT, Gimotty PA, Kirkwood JM, McMasters KM, Mihm MC Jr, Morton DL, Ross MI, Sober AJ, Sondak VK: Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009; 27: 6199-6206.
5. Satzger I, Meier A, Hoy L, Völker B, Kapp A, Hauschild A, Gutzmer R: Sentinel node dissection delays recurrence and prolongs melanoma- related survival: an analysis of 673 patients from a single center with long-term follow-up. Ann Surg Oncol 2010, E-pub ahead of print.
6. Thomas JM: Caution with sentinel node biopsy in melanoma. Br J Surg 2006; 93: 129-130. (Pubitemid 43259595)
7. Gadd MA, Cosimi BA, Yu B, et al: Outcome of patients with melanoma and histopathologically negative sentinel lymph nodes. Arch Surg 1999; 134: 381-387. (Pubitemid 29282079)
8. Carlson GW, Murray DR, Lyles RH, et al: The amount of metastatic melanoma in a sentinel lymph node: does it have prognostic significance? Ann Surg Oncol 2003; 10: 575-581. (Pubitemid 40486923)
9. De Giorgi V, Leporatti G, Massi D, Lo Russo G, Sestini S, Papi F, Dini M, Lotti T: Sentinel lymph nodes in melanoma patients: evaluating the evidence. Oncology 2006; 71: 460-462.
10. Thomas JM: Time to re-evaluate sentinel node biopsy in melanoma post-multicenter selective lymphadenectomy trial. J Clin Oncol 2005; 23: 9443-9444.
11. van Akkooi AC, Verhoef C, Eggermont AM: Importance of tumor load in the sentinel node in melanoma: clinical dilemmas. Nat Rev Clin Oncol 2010; 7: 446-454.
12. van Akkooi AC, Spatz A, Eggermont AM, Mihm M, Cook MG: Expert opinion in melanoma: the sentinel node; EORTC Melanoma Group recommendations on practical methodology of the measurement of the microanatomic location of metastases and metastatic tumour burden. Eur J Cancer 2009; 45: 2736-2742.
13. Nieweg OE, Estourgie SH: What is a sentinel node and what is a false-negative sentinel node? Ann Surg Oncol 2004; 11: 169S-173S.
14. Lam TK, Uren RF, Scolyer RA, Quinn MJ, Shannon KF, Thompson JF: False-negative sentinel node biopsy because of obstruction of lymphatics by metastatic melanoma: the value of ultrasound in conjunction with preoperative lymphoscintigraphy. Melanoma Res 2009; 19: 94-99.
15. Voit C, Mayer T, Kron M, et al: Efficacy of ultrasound B-scan compared with physical examination in follow-up of melanoma patients. Cancer 2001; 91: 2409-2416. (Pubitemid 32552829)
16. Voit C, Van Akkooi AC, Schäfer-Hesterberg G, Schoengen A, Kowalczyk K, Roewert JC, Sterry W, Eggermont AM: Ultrasound morphology criteria predict metastatic disease of the sentinel nodes in patients with melanoma. J Clin Oncol 2010; 28: 847-852.
17. Morton DL, Cochran AJ, Thompson JF: The rationale for sentinel-node biopsy in primary melanoma. Nat Clin Pract Oncol 2008; 5: 510-511.
18. Sanki A, Uren RF, Moncrieff M, Tran KL, Scolyer RA, Lin H, Thompson JF: Targeted high-resolution ultrasound is not an effective substitute for sentinel lymph node biopsy in patients with primary cutaneous melanoma. J Clin Oncol 2009; 27: 5614-5619.
19. Kunte C, Schuh T, Eberle JY, Baumert J, Konz B, Volkenandt M, Ruzicka T, Schmid- Wendtner MH: The use of high-resolution ultrasonography for preoperative detection of metastases in sentinel lymph nodes of patients with cutaneous melanoma. Dermatol Surg 2009; 35: 1757-1765.
20. Goldberg BB, Merton DA, Liu JB, Thakur M, Murphy GF, Needleman L, et al: Sentinel lymph nodes in a swine model with melanoma: contrast-enhanced lymphatic US. Radiology 2004; 230: 727-734. (Pubitemid 38252870)
21. Lurie DM, Seguin B, Schneider PD, Verstraete FJ, Wisner ER: Contrast-assisted ultrasound for sentinel lymph node detection in spontaneously arising canine head and neck tumors. Invest Radiol 2006; 41: 415-421. (Pubitemid 44284204)
22. Nielsen KR, Klyver H, Hougaard Chakera A, Nedergaard L, Hesse B, Bachmann Nielsen M: Sentinel node detection in melanomas using contrast-enhanced ultrasound. Acta Radiol 2009; 50: 412-417.
23. Catalano O, Siani A: Cutaneous melanoma: role of ultrasound in the assessment of locoregional spread. Curr Probl Diagn Radiol 2010; 39: 30-36.
24. Solivetti FM, Di Luca Sidozzi A, Pirozzi G, Coscarella G, Brigida R, Eibenshutz L: Sonographic evaluation of clinically occult intransit and satellite metastases from cutaneous malignant melanoma. Radiol Med 2006; 111: 702-708. (Pubitemid 44426754)
25. Schneider M: SonoVue, a new ultrasound contrast agent. Eur Radiol 1999; 9(suppl 3):S347-S348.
26. Morel DR, Schwieger I, Hohn L, Terrettaz J, Llull JB, Cornioley YA, Schneider M: Human pharmacokinetics and safety evaluation of SonoVue, a new contrast agent for ultrasound imaging. Invest Radiol 2000; 35: 80-85. (Pubitemid 30033610)
27. Correas JM, Bridal L, Lesavre A, Méjean A, Claudon M, Hélénon O: Ultrasound contrast agents: properties, principles of action, tolerance and artifacts. Eur Radiol 2001; 11: 1316-1328. (Pubitemid 32755614)
28. Bauer A, Solbiati L, Weissman N: Ultrasound imaging with SonoVue : low-mechanical index real-time imaging. Acad Radiol 2002; 9(suppl 2):S282-S284. (Pubitemid 34857695)
29. Greis C: Technology overview: SonoVue (Bracco, Milan). Eur Radiol 2004; 14(suppl 8):P11-P15.